BioSpace News Archive

Drug Development

A Wave of Regenerative Therapies are Being Developed to Treat Patient Needs

Artificial body parts have been around for some time. Patients have access to artificial limbs, hearts, eyes, skin and more thanks to the innovation of biomedical engineers. As technology improves, so do the advancements in these man-made devices.

May 6, 2018
·
3 min read
·
Alex Keown
Drug Development

Recent Movement in Anti-Infectives Point to a Growing Market

On May 1, the U.S. Food and Drug Administration (FDA) granted Scynexi’s oral formulation of SCY-078 to treat vulvovaginal candidiasis (VVC) and recurrent VVC both Qualified Infectious Diseases Product (QIDP) and Fast Track Designation.

May 6, 2018
·
3 min read
·
Mark Terry